SCHEMBL4437207

SCHEMBL4437207

Cc1onc(O)c1CCC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.41
KDM4E B2RXH2 2/20 0.41
GRIA1 P42261 2/20 0.38
GRIA3 P42263 2/20 0.38
HSD17B10 Q99714 3/20 0.38
GAA P10253 3/20 0.38
FFAR4 Q5NUL3 1/20 0.38
GRIA2 P42262 1/20 0.37
GRIA4 P48058 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 3/20 0.36
GLA P06280 2/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL314801 0.83 MEN1 (0.45) NPSR1KDM4EHSD17B10GAANPC1
SCHEMBL84167 0.80 GLA (0.35) KDM4EGRIA1GRIA3GAAGRIA2
SCHEMBL9147234 0.76 GAA (0.32) KDM4EGRIA1GRIA3GAA
SCHEMBL8555482 0.76 GRIA1 (0.46) NPSR1KDM4EGRIA1GRIA3HSD17B10
Propionic Acid SCHEMBL9538907 0.75 GRIA1 (0.40) KDM4EGRIA1GRIA3GAAGRIA2
SCHEMBL3731488 0.75 GRIA1 (0.54) GRIA1GRIA3GRIA2GRIA4ALDH1A1
SCHEMBL9014849 0.73 TLR8 (0.34) GRIA1GRIA3GAA
(R,S)-Ampa SCHEMBL23242452 0.73 GRIA1 (0.58) GRIA1GRIA3GRIA2GRIA4ALDH1A1
(R,S)-Ampa SCHEMBL19086372 0.73 GRIA1 (0.58) GRIA1GRIA3GRIA2GRIA4ALDH1A1
SCHEMBL17755880 0.72 MITF (0.38) NPSR1FFAR4NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066323-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING COMBINATIONS OF AN AMPA/KAINATE ANTAGONISTIC COMPOUND AND AN INHIBITOR OF A MULTIDRUG RESISTANCE PROTEIN NeuroSearch AS (DK) 2009-06-10 EP claimed
WO-2008031831-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING COMBINATIONS OF AN AMPA/KAINATE ANTAGONISTIC COMPOUND AND AN INHIBITOR OF A MULTIDRUG RESISTANCE PROTEIN NEUROSEARCH A/S (DK) 2008-03-20 WO claimed
US-7192931-B2 Treatment of demyelinating diseases NEUREN PHARMACEUTICALS LTD. (NZ) 2007-03-20 US claimed
EP-0859763-A1 DIHYDROPHTHALAZINE ANTAGONISTS OF EXCITATORY AMINO ACID RECEPTORS Bearsden Bio, Inc. (US) 1998-08-26 EP claimed
WO-2025030033-A1 APILIMOD COMPOSITIONS AND METHODS OF USE ORPHAI THERAPEUTICS INC. (US) 2025-02-06 WO disclosed
CN-116930351-A Method for measuring related substances of key starting materials of pirenzepine by HPLC 上海现代制药股份有限公司 2023-10-24 CN disclosed
EP-4188382-A1 ADMINISTRATION OF MODULATORS OF 5-HT AND/OR AMPA RECEPTORS FOR TREATING NEUROLOGICAL CONDITIONS The Royal Institution for the Advancement of Learning / McGill University (CA) 2023-06-07 EP disclosed
WO-2022023813-A1 ADMINISTRATION OF MODULATORS OF 5-HT AND/OR AMPA RECEPTORS FOR TREATING NEUROLOGICAL CONDITIONS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2022-02-03 WO disclosed
CN-113425690-A Perampanel orally disintegrating tablet and preparation method thereof 北京万全德众医药生物技术有限公司 2021-09-24 CN disclosed
CN-106389367-B Perampanel coated tablet pharmaceutical composition 杭州朱养心药业有限公司 2020-12-18 CN disclosed
CN-107616969-B Rapidly disintegrating pharmaceutical composition of Perampanel tablets 杭州朱养心药业有限公司 2020-09-18 CN disclosed
US-20180318279-A1 TOPICAL COMPOSITIONS PROVIDING PAIN RELIEF AND METHODS OF USE THEREOF RUSH UNIVERSITY MEDICAL CENTER (US) 2018-11-08 US disclosed
US-20030100482-A1 NMDA oxidizing agents for protecting neurons from injury THE CHILDREN'S MEDICAL CENTER CORPORATION, INC., A MASSACHUSETTS CORPORATION 2003-05-29 US disclosed
US-6525017-B1 Using glutathiane to protect neurons from injury THE CHILDREN'S MEDICAL CENTER CORPORATION 2003-02-25 US disclosed
EP-1244638-A2 PHENANTHRYL PIPERAZINYL DICARBOXYLIC ACIDS AS SELECTIVE NMDA RECEPTOR MODULATING AGENTS UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) 2002-10-02 EP disclosed
WO-2001044205-A2 PHENANTHRYL PIPERAZINYL DICARBOXYLIC ACIDS AS SELECTIVE NMDA RECEPTOR MODULATING AGENTS UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) 2001-06-21 WO disclosed
WO-1995007887-A1 INDOLE DERIVATIVES AS ANTAGONISTS OF EXCITATORY AMINO ACIDS GLAXO S.P.A. (IT) 1995-03-23 WO disclosed
EP-0486621-A4 NMDA OXIDIZING AGENTS FOR PROTECTING NEURONS FROM INJURY 1993-03-31 EP disclosed
EP-0486621-A1 NMDA OXIDIZING AGENTS FOR PROTECTING NEURONS FROM INJURY The Children's Medical Center Corporation (US) 1992-05-27 EP disclosed
WO-1991002810-A1 NMDA OXIDIZING AGENTS FOR PROTECTING NEURONS FROM INJURY THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 1991-03-07 WO disclosed